Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) CAO Dana Boyle sold 1,193 shares of the business's stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $14.28, for a total value of $17,036.04. Following the completion of the sale, the chief accounting officer owned 187,168 shares of the company's stock, valued at $2,672,759.04. The trade was a 0.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.
Liquidia Technologies Stock Down 1.3%
Shares of LQDA stock traded down $0.20 during trading hours on Friday, reaching $14.41. 929,859 shares of the company's stock were exchanged, compared to its average volume of 1,301,913. The stock's 50 day moving average is $14.88 and its 200-day moving average is $14.48. The company has a market cap of $1.23 billion, a price-to-earnings ratio of -9.14 and a beta of -0.01. The company has a current ratio of 2.93, a quick ratio of 2.91 and a debt-to-equity ratio of 2.08. Liquidia Technologies, Inc. has a fifty-two week low of $8.26 and a fifty-two week high of $19.41.
Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). The company had revenue of $3.12 million for the quarter, compared to analysts' expectations of $3.23 million. Liquidia Technologies had a negative net margin of 903.80% and a negative return on equity of 177.91%. Analysts predict that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on LQDA. Bank of America reduced their price objective on shares of Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Wednesday, June 11th. Needham & Company LLC reissued a "buy" rating on shares of Liquidia Technologies in a research note on Monday, June 2nd. Oppenheimer set a $13.00 price objective on shares of Liquidia Technologies and gave the stock an "underperform" rating in a research note on Monday, May 19th. Wells Fargo & Company boosted their price objective on shares of Liquidia Technologies from $23.00 to $25.00 and gave the stock an "overweight" rating in a research note on Thursday, June 12th. Finally, Raymond James Financial boosted their price objective on shares of Liquidia Technologies from $27.00 to $29.00 and gave the stock a "strong-buy" rating in a research note on Friday, May 9th. One analyst has rated the stock with a sell rating, one has issued a hold rating, six have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Liquidia Technologies presently has a consensus rating of "Moderate Buy" and an average price target of $26.89.
Check Out Our Latest Analysis on LQDA
Institutional Investors Weigh In On Liquidia Technologies
Several hedge funds have recently added to or reduced their stakes in LQDA. Corebridge Financial Inc. boosted its stake in shares of Liquidia Technologies by 2.3% during the 4th quarter. Corebridge Financial Inc. now owns 31,516 shares of the company's stock worth $371,000 after acquiring an additional 694 shares in the last quarter. Ballentine Partners LLC raised its holdings in Liquidia Technologies by 10.2% in the 2nd quarter. Ballentine Partners LLC now owns 12,139 shares of the company's stock valued at $151,000 after acquiring an additional 1,119 shares during the last quarter. GAMMA Investing LLC raised its holdings in Liquidia Technologies by 65.6% in the 1st quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after acquiring an additional 1,173 shares during the last quarter. Cetera Investment Advisers raised its holdings in Liquidia Technologies by 4.3% in the 4th quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock valued at $367,000 after acquiring an additional 1,277 shares during the last quarter. Finally, Valmark Advisers Inc. increased its holdings in shares of Liquidia Technologies by 7.4% during the 1st quarter. Valmark Advisers Inc. now owns 18,641 shares of the company's stock worth $275,000 after buying an additional 1,283 shares during the last quarter. 64.54% of the stock is owned by hedge funds and other institutional investors.
About Liquidia Technologies
(
Get Free Report)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Read More
Before you consider Liquidia Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia Technologies wasn't on the list.
While Liquidia Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
